每年的科研成果
每年的科研成果
- 8 个结果
搜索结果
-
2019
The clinical utility of baseline cardiac assessments prior to adjuvant anthracycline chemotherapy in breast cancer: a systematic review and meta-analysis
O’Brien, P., Matheson, K., Jeyakumar, A., Anderson, K. & Younis, T., 4月 15 2019, 在: Breast Cancer Research and Treatment. 174, 2, 页码 357-363 7 页码科研成果: 期刊稿件 › 文献综述 › 同行评审
12 引用 （Scopus） -
2016
Cost-effectiveness of febrile neutropenia prevention with primary versus secondary G-CSF prophylaxis for adjuvant chemotherapy in breast cancer: a systematic review
Younis, T., Rayson, D., Jovanovic, S. & Skedgel, C., 10月 1 2016, 在: Breast Cancer Research and Treatment. 159, 3, 页码 425-432 8 页码科研成果: 期刊稿件 › 文献综述 › 同行评审
12 引用 （Scopus） -
Endocrine therapy for breast cancer prevention in high-risk women: Clinical and economic considerations
Groom, A. G. & Younis, T., 3月 3 2016, 在: Expert Review of Pharmacoeconomics and Outcomes Research. 16, 2, 页码 245-255 11 页码科研成果: 期刊稿件 › 文献综述 › 同行评审
4 引用 （Scopus） -
2014
Pertuzumab in human epidermal growth-factor receptor 2-positive breast cancer: Clinical and economic considerations
Lamond, N. W. D. & Younis, T., 5月 16 2014, 在: International Journal of Women's Health. 6, 1, 页码 509-521 13 页码科研成果: 期刊稿件 › 文献综述 › 同行评审
开放访问8 引用 （Scopus） -
2013
Is the 21-gene recurrence score a cost-effective assay in endocrine-sensitive node-negative breast cancer?
Lamond, N. W. D., Skedgel, C. & Younis, T., 4月 2013, 在: Expert Review of Pharmacoeconomics and Outcomes Research. 13, 2, 页码 243-250 8 页码科研成果: 期刊稿件 › 文献综述 › 同行评审
14 引用 （Scopus） -
2012
Primary G-CSF prophylaxis for adjuvant TC or FEC-D chemotherapy outside of clinical trial settings: A systematic review and meta-analysis
Younis, T., Rayson, D. & Thompson, K., 10月 2012, 在: Supportive Care in Cancer. 20, 10, 页码 2523-2530 8 页码科研成果: 期刊稿件 › 文献综述 › 同行评审
48 引用 （Scopus） -
Trastuzumab for HER2-positive metastatic breast cancer: Clinical and economic considerations
Jeyakumar, A. & Younis, T., 2012, 在: Clinical Medicine Insights: Oncology. 6, 页码 179-187 9 页码科研成果: 期刊稿件 › 文献综述 › 同行评审
开放访问28 引用 （Scopus） -
2008
The cost burden of trastuzumab and bevacizumab therapy for solid tumours in Canada
Drucker, A., Skedgel, C., Virik, K., Rayson, D., Sellon, M. & Younis, T., 2008, 在: Current Oncology. 15, 3, 页码 21-27 7 页码科研成果: 期刊稿件 › 文献综述 › 同行评审
开放访问34 引用 （Scopus）